stockrow
Saturday 7 November 2026
Export DNA’s income statement to Excel — free account
Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $170.2 million, down 25.1% from fiscal 2024.
- Revenue
- −59.4%
- EPS
- +31.8%
- Free cash flow
- −16.4%
Quarter to June 2026, against a year earlier
11.19
1.23
+12.35%
Follow DNA
Alert me
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | |
|---|---|---|---|---|---|---|---|
Cash and Short Term Investments |
422.62 | 561.57 | 944.07 | 1,315.79 | 1,550.00 | 380.80 | — |
Receivables |
24.26 | 22.44 | 17.90 | 82.47 | 136.14 | 21.91 | — |
Inventory |
— | — | — | — | 3.36 | 2.74 | — |
Total current assets |
471.84 | 602.74 | 1,001.75 | 1,450.08 | 1,723.05 | 426.54 | — |
Property, Plant, Equpment (Net) |
167.78 | 203.72 | 188.19 | 314.77 | 145.77 | 121.44 | — |
Long-Term Investments |
15.07 | 48.70 | 78.57 | 113.73 | 115.23 | 103.12 | — |
Long-term receivables |
— | — | — | — | — | 13.30 | — |
Goodwill and Intangible Assets (Total) |
56.92 | 72.51 | 131.98 | 171.25 | 42.95 | 5.15 | 0.00 |
Long-term assets (Other) |
47.17 | 55.34 | 58.06 | 88.73 | 43.99 | 5.60 | — |
Total non-current assets |
647.86 | 774.71 | 663.59 | 1,089.24 | 347.95 | 248.61 | — |
Total Assets |
1,119.70 | 1,377.45 | 1,665.34 | 2,539.32 | 2,070.99 | 675.15 | — |
Accounts Payable |
10.57 | 14.17 | 9.32 | 10.45 | 8.19 | 13.89 | — |
Accrued Expenses |
66.46 | 65.39 | 110.05 | 114.69 | 93.33 | 30.51 | — |
Current Part of Capital Lease |
— | — | — | — | — | — | 0.00 |
Current Part of Taxes to Pay |
— | — | — | — | — | — | 0.00 |
Current Revenue (Deferred) |
18.95 | 27.71 | 44.49 | 47.82 | 33.24 | 28.82 | — |
Total current liabilities |
95.97 | 107.27 | 163.86 | 172.96 | 134.76 | 73.22 | — |
Long Term Debt (Total) |
— | — | — | — | 22.28 | 16.52 | — |
Non-current Revenue (Deferred) |
75.18 | 98.78 | 158.06 | 174.77 | 174.74 | 112.33 | 0.00 |
Minority Interests |
— | — | — | — | — | — | 0.00 |
Non-current Liabilities (Other) |
22.88 | 16.58 | 24.43 | 42.06 | 171.83 | 3.03 | — |
Total non-current liabilities |
515.14 | 554.13 | 404.33 | 630.08 | 368.85 | 131.88 | — |
Total liabilities |
611.11 | 661.39 | 568.19 | 803.04 | 503.61 | 205.10 | — |
Additional Paid In Capital |
6,657.05 | 6,555.42 | 6,386.19 | 6,136.38 | 3,804.84 | 929.13 | 0.00 |
Preferred Stock (Total) |
— | — | — | — | — | — | 0.00 |
Common Stock (Net) |
0.01 | 0.01 | 0.01 | 0.19 | 0.16 | 0.13 | 0.00 |
Retained Earnings |
(6,150.32) | (5,837.56) | (5,290.53) | (4,397.66) | (2,297.92) | (467.88) | — |
Treasury Stock |
— | — | — | — | — | — | 0.00 |
Shareholders Equity (Other) |
— | — | — | — | — | — | 0.00 |
Common Equity (Total) |
508.59 | 716.06 | 1,097.15 | 1,736.28 | 1,567.38 | 470.05 | — |
Shareholders Equity (Total) |
508.59 | 716.06 | 1,097.15 | 1,736.28 | 1,567.38 | 470.05 | — |
Shareholders Equity and Liabilities (Total) |
1,119.70 | 1,377.45 | 1,665.34 | 2,539.32 | 2,070.99 | 675.15 | — |
Shares (Common) |
58.21 | 54.37 | 50.03 | 47.30 | 40.28 | 32.21 | — |
Shareholders Equity (Tangible) |
451.67 | 643.55 | 965.17 | 1,565.03 | 1,524.43 | 464.90 | — |
Net Debt |
(422.62) | (561.57) | (944.07) | (1,315.79) | (1,527.72) | (364.28) | — |
Total Debt |
— | — | — | 413.00 | 22.28 | 16.52 | — |
In millions of $ except per-share values · columns are period end dates · fundamentals updated 26 Oct 2026